Yasuko Furumoto

2.3k total citations
22 papers, 1.9k citations indexed

About

Yasuko Furumoto is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, Yasuko Furumoto has authored 22 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 7 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Yasuko Furumoto's work include Mast cells and histamine (14 papers), Asthma and respiratory diseases (7 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Yasuko Furumoto is often cited by papers focused on Mast cells and histamine (14 papers), Asthma and respiratory diseases (7 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Yasuko Furumoto collaborates with scholars based in United States, Japan and Mexico. Yasuko Furumoto's co-authors include Massimo Gadina, Juan Rivera, Sandra Odom, John J. O’Shea, Martina Kovářová, Claudia González‐Espinosa, Valentino Parravicini, Lawrence E. Samelson, Shin-ichiroh Saitoh and Chisei Ra and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Yasuko Furumoto

22 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasuko Furumoto United States 19 1.3k 660 402 347 276 22 1.9k
Sandra Odom United States 18 1.4k 1.1× 584 0.9× 588 1.5× 263 0.8× 458 1.7× 21 1.8k
Frank C. Stomski Australia 23 800 0.6× 727 1.1× 130 0.3× 89 0.3× 192 0.7× 35 1.8k
W E Serafin United States 19 1.0k 0.8× 523 0.8× 251 0.6× 121 0.3× 431 1.6× 24 1.5k
Yves Chicheportiche Switzerland 15 767 0.6× 813 1.2× 125 0.3× 107 0.3× 119 0.4× 22 1.6k
Marita J. Walmsley United Kingdom 11 805 0.6× 521 0.8× 51 0.1× 287 0.8× 285 1.0× 13 1.6k
Svetlana A. Didichenko Switzerland 17 652 0.5× 756 1.1× 287 0.7× 95 0.3× 160 0.6× 27 1.6k
Palaniswami Rathanaswami Canada 16 420 0.3× 358 0.5× 93 0.2× 201 0.6× 101 0.4× 21 1.2k
Julius Kahn United States 11 391 0.3× 497 0.8× 84 0.2× 96 0.3× 520 1.9× 12 1.1k
Vanessa Ott United States 13 498 0.4× 342 0.5× 360 0.9× 55 0.2× 287 1.0× 17 1.1k
Fei-Hua Qiu United States 9 607 0.5× 685 1.0× 55 0.1× 55 0.2× 213 0.8× 13 1.5k

Countries citing papers authored by Yasuko Furumoto

Since Specialization
Citations

This map shows the geographic impact of Yasuko Furumoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuko Furumoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuko Furumoto more than expected).

Fields of papers citing papers by Yasuko Furumoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuko Furumoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuko Furumoto. The network helps show where Yasuko Furumoto may publish in the future.

Co-authorship network of co-authors of Yasuko Furumoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuko Furumoto. A scholar is included among the top collaborators of Yasuko Furumoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuko Furumoto. Yasuko Furumoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bing, So Jin, Cancan Lyu, Biying Xu, et al.. (2020). Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells.. PubMed. 26. 641–651. 20 indexed citations
2.
Vian, Laura, Nathalia Gazaniga, Christine Liu, et al.. (2019). JAK Inhibition Differentially Affects NK Cell and ILC1 Homeostasis. Frontiers in Immunology. 10. 11 indexed citations
3.
Gadina, Massimo, Nathalia Gazaniga, Laura Vian, & Yasuko Furumoto. (2017). Small molecules to the rescue: Inhibition of cytokine signaling in immune-mediated diseases. Journal of Autoimmunity. 85. 20–31. 68 indexed citations
4.
Furumoto, Yasuko, Carolyne K. Smith, Luz P. Blanco, et al.. (2016). Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction. Arthritis & Rheumatology. 69(1). 148–160. 169 indexed citations
5.
Vahedi, Golnaz, Yuka Kanno, Yasuko Furumoto, et al.. (2015). Super-enhancers delineate disease-associated regulatory nodes in T cells. Nature. 520(7548). 558–562. 271 indexed citations
6.
Furumoto, Yasuko & Massimo Gadina. (2013). The Arrival of JAK Inhibitors: Advancing the Treatment of Immune and Hematologic Disorders. BioDrugs. 27(5). 431–438. 82 indexed citations
7.
Okiyama, Naoko, Yasuko Furumoto, Wanxia Li Tsai, et al.. (2013). Reversal of CD8 T-Cell–Mediated Mucocutaneous Graft-Versus-Host-Like Disease by the JAK Inhibitor Tofacitinib. Journal of Investigative Dermatology. 134(4). 992–1000. 55 indexed citations
8.
Álvarez‐Errico, Damiana, Yumi Yamashita, Ryo Suzuki, et al.. (2010). Functional Analysis of Lyn Kinase A and B Isoforms Reveals Redundant and Distinct Roles in FcεRI-Dependent Mast Cell Activation. The Journal of Immunology. 184(9). 5000–5008. 33 indexed citations
9.
Iwaki, Shoko, Jiřı́ Špička, Christine Tkaczyk, et al.. (2007). Kit- and FcɛRI-induced differential phosphorylation of the transmembrane adaptor molecule NTAL/LAB/LAT2 allows flexibility in its scaffolding function in mast cells. Cellular Signalling. 20(1). 195–205. 52 indexed citations
10.
Yamashita, Yumi, Nicolas Charles, Yasuko Furumoto, et al.. (2007). Cutting Edge: Genetic Variation Influences FcεRI-Induced Mast Cell Activation and Allergic Responses. The Journal of Immunology. 179(2). 740–743. 63 indexed citations
11.
Furumoto, Yasuko, Ana Olivera, Yasuomi Takagi, et al.. (2006). Cutting Edge: Lentiviral Short Hairpin RNA Silencing of PTEN in Human Mast Cells Reveals Constitutive Signals That Promote Cytokine Secretion and Cell Survival. The Journal of Immunology. 176(9). 5167–5171. 65 indexed citations
12.
Olivera, Ana, Nicole Urtz, Kiyomi Mizugishi, et al.. (2005). IgE-dependent Activation of Sphingosine Kinases 1 and 2 and Secretion of Sphingosine 1-Phosphate Requires Fyn Kinase and Contributes to Mast Cell Responses. Journal of Biological Chemistry. 281(5). 2515–2525. 120 indexed citations
13.
Furumoto, Yasuko, Claudia González‐Espinosa, Gregorio Gomez, et al.. (2004). Rethinking the Role of Src Family Protein Tyrosine Kinases in the Allergic Response: New Insights on the Functional Coupling of the High Affinity IgE Receptor. Immunologic Research. 30(2). 241–254. 18 indexed citations
14.
Furumoto, Yasuko, Satoshi Nunomura, Tomoyoshi Terada, Juan Rivera, & Chisei Ra. (2004). The FcϵRIβ Immunoreceptor Tyrosine-based Activation Motif Exerts Inhibitory Control on MAPK and IκB Kinase Phosphorylation and Mast Cell Cytokine Production. Journal of Biological Chemistry. 279(47). 49177–49187. 92 indexed citations
15.
Odom, Sandra, Gregorio Gomez, Martina Kovářová, et al.. (2004). Negative Regulation of Immunoglobulin E–dependent Allergic Responses by Lyn Kinase. The Journal of Experimental Medicine. 199(11). 1491–1502. 182 indexed citations
16.
Parravicini, Valentino, Massimo Gadina, Martina Kovářová, et al.. (2002). Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nature Immunology. 3(8). 741–748. 393 indexed citations
17.
Rivera, Juan, Yasuko Furumoto, Claudia González‐Espinosa, et al.. (2002). Macromolecular protein signaling complexes and mast cell responses: a view of the organization of IgE-dependent mast cell signaling. Molecular Immunology. 38(16-18). 1253–1258. 26 indexed citations
18.
Yamaguchi, Masao, Koichi Hirai, Akiko Komiya, et al.. (2001). Regulation of mouse mast cell surface FcεRI expression by dexamethasone. International Immunology. 13(7). 843–851. 34 indexed citations
19.
Furumoto, Yasuko, Shûichi Hiraoka, Keiko Kawamoto, et al.. (2000). Polymorphisms in FcϵRI β Chain Do Not Affect IgE-Mediated Mast Cell Activation. Biochemical and Biophysical Research Communications. 273(2). 765–771. 30 indexed citations
20.
Hiraoka, Shûichi, et al.. (1999). Fc receptor β subunit is required for full activation of mast cells through Fc receptor engagement. International Immunology. 11(2). 199–207. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra Odom Breakdown of academic impact, for papers by Frank C. Stomski Breakdown of academic impact, for papers by W E Serafin Breakdown of academic impact, for papers by Yves Chicheportiche Breakdown of academic impact, for papers by Marita J. Walmsley Breakdown of academic impact, for papers by Svetlana A. Didichenko Breakdown of academic impact, for papers by Palaniswami Rathanaswami Breakdown of academic impact, for papers by Julius Kahn Breakdown of academic impact, for papers by Vanessa Ott Breakdown of academic impact, for papers by Fei-Hua Qiu
Rankless by CCL
2026